학술논문

Quality of Life and Patient Reported Outcome (PRO) in Patients Receiving High and Moderate Emetogenic Chemotherapy (Ctx) - Results of a German Non-Interventional Study with NEPA - a Netupitant/Palonosetron Fixed Dose Combination
Document Type
Journal
Source
BLOOD; DEC 7 2017, 130 2p. Supplement: 1
Subject
Language
English
ISSN
15280020